A concerning trend is emerging in Japan: a diabetes medication is being widely adopted by young individuals solely for rapid weight loss, sparking serious health warnings from medical professionals.
It appears a type 2 diabetes drug, which has received approval from Japan's health ministry, is now being sought after by younger demographics eager for quick slimming results. This escalating phenomenon is largely propelled by social media endorsements, leading doctors to voice grave concerns about the potential health hazards stemming from the drug's use beyond its intended medical purpose.
Many individuals are reportedly acquiring this medication through online channels, often after only brief consultations. Some have even experienced severe adverse reactions, prompting experts to highlight the pervasive influence of appearance-centric values that are being amplified across digital platforms and various media outlets.
Consider the case of a woman in her twenties, who works at a cabaret club in Osaka. Her introduction to the drug, known commercially as Mounjaro, came through a TikTok influencer detailing their personal weight loss journey. Intrigued and driven by a desire to achieve a slimmer physique, she proceeded to a clinic's website, completed a phone consultation, and had the medication delivered to her. Post-treatment, her weight dropped to 42 kilograms at a height of 160 centimeters, resulting in a body mass index (BMI) below 18.5, which medically classifies her as underweight. She explained, "I feel I have to stay as slim as possible because my job puts a lot of focus on appearance."
Similarly, a 35-year-old office worker decided to use the drug in preparation for her wedding. Her decision was influenced by a nurse at a beauty clinic who shared her own successful weight loss using the same medication on social media. Inspired by this post, the woman visited the clinic for a prescription.
Professor Keiko Kishimoto, a specialist in social pharmacology at Showa Medical University, who researches the appropriate use of medications, pointed out that the increasing reliance on remote consultations (online or by phone) significantly hinders a clinician's ability to thoroughly assess a patient's overall health. She stated, "When the interaction is only by phone or online, there's a limited amount of information a doctor can glean about the patient's condition." Furthermore, she added, "It is not consistent with medical ethics for professionals to promote medicines for non-medical purposes through advertising or discount campaigns."
But here's where it gets controversial... The narrative around this drug's misuse isn't just about individual choices; it touches upon broader societal pressures.
Another young woman, aged 22, also employed in a cabaret club, recounted a frightening experience after her initial injection, leading her to cease usage immediately. "It was so uncomfortable that once was enough," she shared. "People shouldn't take it casually." She described experiencing nausea, a mild fever, and feelings of depression that lingered for about three days. Her appetite diminished drastically, to the point where she sometimes consumed only half a block of tofu in a day.
Professor Kishimoto emphasized that individuals using the drug for unapproved reasons might not be eligible for support under the Relief Services for Adverse Health Effects system. This system is specifically designed for patients who experience side effects while undergoing treatment for legitimate medical conditions. Pharmaceutical companies themselves have issued advisories, reiterating that the drug's safety and efficacy outside of diabetes treatment remain unconfirmed.
Experts believe this surge in misuse is a direct reflection of a pervasive societal belief that equates thinness with beauty. A 2024 survey conducted by the health ministry revealed a startling statistic: approximately one in five to six women in their twenties are currently underweight.
In response to these growing concerns, the Japan Society for the Study of Obesity has proposed the establishment of a new syndrome to specifically address health issues linked to being underweight and malnourished. They warn that social media and fashion magazines may be inadvertently encouraging young women to adopt increasingly restrictive dietary habits.
Yoshifumi Tamura, executive director of the My Well Body Council, an organization advocating for body diversity, stressed the importance of young people understanding that images presented on social media and in mainstream media are frequently altered or selectively chosen. "Online and media content can be distorted, and people need to understand that it doesn't always reflect reality," he commented. "This is already being taught in schools in the U.S. and Europe, and Japan also needs classes at the compulsory education level to help students understand their own body image and appreciate a range of body shapes."
And this is the part most people miss... While the focus is on the drug, the underlying issue is the societal pressure to conform to a specific, often unrealistic, body image. Do you believe social media platforms have a responsibility to curb the promotion of potentially harmful weight-loss trends? Or should the onus be entirely on the individual to discern healthy practices? Let us know your thoughts in the comments below!
